Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Yes, We Can, But Should We? Ethical Considerations in Reporting Germline Findings From Paired Tumor-Normal Genomic Testing in Patients With Advanced Cancer.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology - 10 Apr 2023

Hunter Cynthia L, Helft Paul R

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Genetic Predisposition to Disease
Share to Genetic Testing
Share to Germ Cells

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Germ-Line Mutation

Share to Neoplasms

Source

Identifiers

PMID: 36469841
DOI: 10.1200/JCO.22.00796

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Yes, We Can, But Should We? Ethical Considerations in Reporting Germline Findings From Paired Tumor-Normal Genomic Testing in Patients With Advanced Cancer.PMID 36469841Read ↗

The Future of Parallel Tumor and Germline Genetic Testing: Is There a Role for All Patients With Cancer?Semantic proximity Read ↗

Germline Findings in Tumor-Only Sequencing: Points to Consider for Clinicians and Laboratories.Semantic proximity Read ↗

Clinically significant germline pathogenic variants are missed by tumor genomic sequencingSemantic proximity Read ↗

Germline sequencing for presumed germline pathogenic variants via tumor-only comprehensive genomic profilingSemantic proximity Read ↗

Aligning Germline Cancer Predisposition With Tumor-Based Next-Generation Sequencing for Modern Oncology Diagnosis, Interception, and Therapeutic DevelopmentSemantic proximity Read ↗

Your DNA is not your diagnosis: getting diagnoses right following secondary genomic findings.Semantic proximity Read ↗

Clinical tumor sequencing: an incidental casualty of the American College of Medical Genetics and Genomics recommendations for reporting of incidental findings.Semantic proximity Read ↗

Mutation Detection in Patients With Advanced Cancer by Universal Sequencing of Cancer-Related Genes in Tumor and Normal DNA vs Guideline-Based Germline Testing.Semantic proximity Read ↗

The emerging significance of secondary germline testing in cancer genomics.Semantic proximity Read ↗

Genetics specialists’ perspectives on disclosure of genomic incidental findings in the clinical settingSemantic proximity Read ↗

Points to consider for reporting of germline variation in patients undergoing tumor testing: a statement of the American College of Medical Genetics and Genomics (ACMG)Semantic proximity Read ↗

Germline reflex BRCA1/2 testing following tumor-only comprehensive genomic profiling: why, when, and how.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.